Sage Therapeutics said Biogen has terminated the companies' license agreement with respect to its SAGE-324 molecule, a investigational drug targeting essential tremor and epilepsy. The move comes ...
BOCA RATON, Fla. (CBS12) — Doctors are calling it a medical breakthrough for people who suffer from what are called essential tremors. The new technology treats the neurological causes of ...
Two months of deliberations have failed to convince Biogen to continue developing the drug candidate ... to get the deal off the ground. The essential tremor failure deprived Sage of the chance ...
The focused ultrasound surgery has been approved by the U.S. Food and Drug Administration since 2016 and is backed by years of data, which has shown most patients experience immediate, significant ...
September 24, 2024 • Nate Cross has become a powerful force behind the scenes of contemporary American music, onstage and on record as one of the key members of drone-rock ensemble Water Damage ...